• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
In the last 7 days
China welcomes new US$1 billion Sanofi project in Beijing South China Morning Post12:01 3-Dec-24
In the last month
Sanofi-Backed Resalis Brings MicroRNA To Obesity Scrip Pharma Intelligence16:52 29-Nov-24
Business leaders pledge to include disability in sustainability efforts International Labour Organization14:05 22-Nov-24
Two-Step M6P Antibody Conjugations Sans Enzyme Remodeling Genetic Engineering and Biotechnology News17:44 20-Nov-24
Condition Watch: Respiratory Syncytial Virus Pharmacy Times15:36 20-Nov-24
BioNJ Unveils "Time Off for Clinical Trials" Initiative PR Newswire (Press Release)15:03 20-Nov-24
Sanofi investment to enhance antibody bioproduction in France European Pharmaceutical Review15:20 18-Nov-24
FDA to review Sanofi, Regeneron’s Dupixent sBLA for CSU Pharmaceutical Business Review11:41 15-Nov-24
Inhibrx Biosciences Reports Third Quarter 2024 Financial Results PR Newswire (Press Release)21:26 14-Nov-24
AI Collaboration Between Sanofi and Healx Will Target Novel Rare Diseases Indications Genetic Engineering and Biotechnology News03:04 14-Nov-24
Eli Lilly, Novo Nordisk, and Sanofi must make insulin pens available at $1 each Doctors Without Borders (Press Release)17:46 12-Nov-24
Sanofi Becomes Oversold Nasdaq21:08 11-Nov-24
Stock Watch: Sanofi And Roche Depress European Pharma Mood Scrip Pharma Intelligence10:45 9-Nov-24
view more headlines
6 Dec 14:17

About our Sanofi news

Latest news on Sanofi: pharmaceutical innovations, drug pipelines, financial performance, strategic partnerships, and global health initiatives from the French multinational healthcare company.

Sanofi, a global leader in the pharmaceutical industry, continues to make significant strides in healthcare innovation and drug development. With a diverse portfolio spanning vaccines, rare diseases, multiple sclerosis, oncology, immunology, and consumer healthcare, the company remains at the forefront of addressing global health challenges. Recent developments have seen Sanofi focusing on expanding its presence in emerging markets while strengthening its research and development capabilities.

In the realm of drug development, Sanofi has been making headlines with its advancements in mRNA technology, building on the momentum gained during the COVID-19 pandemic. The company's pipeline includes promising candidates in oncology and immunology, with several drugs in late-stage clinical trials. Sanofi's continued investment in rare disease treatments has also yielded notable results, with new therapies showing potential in addressing previously untreatable conditions.

On the financial front, Sanofi has demonstrated resilience in the face of global economic challenges. The company's strategic focus on high-growth areas and cost optimization has contributed to solid financial performance. Analysts are closely watching Sanofi's moves in the mergers and acquisitions space, as the company seeks to bolster its portfolio and technological capabilities through strategic partnerships and targeted acquisitions.

Sanofi's commitment to global health extends beyond its commercial operations. The company has been actively involved in initiatives to improve access to medicines in low and middle-income countries. Recent partnerships with international organizations and NGOs have focused on combating neglected tropical diseases and improving vaccination rates in underserved communities. Sanofi's efforts in sustainable development and reducing its environmental footprint have also gained recognition in the industry.

Innovation remains at the heart of Sanofi's strategy. The company has been investing heavily in digital health solutions and artificial intelligence to enhance drug discovery and development processes. Collaborations with tech companies and academic institutions have positioned Sanofi at the intersection of healthcare and technology, promising to revolutionize patient care and treatment outcomes.

Stay informed about Sanofi's latest breakthroughs, market performance, and global initiatives with our comprehensive NewsNow feed. From cutting-edge research to strategic business moves, our curated content from reliable sources keeps you up-to-date on all aspects of this pharmaceutical giant's activities shaping the future of healthcare.


Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.